Financhill
Buy
55

CPRX Quote, Financials, Valuation and Earnings

Last price:
$21.26
Seasonality move :
6.88%
Day range:
$21.01 - $21.41
52-week range:
$13.12 - $24.27
Dividend yield:
0%
P/E ratio:
18.03x
P/S ratio:
5.63x
P/B ratio:
3.84x
Volume:
1.7M
Avg. volume:
1M
1-year change:
48.74%
Market cap:
$2.5B
Revenue:
$398.2M
EPS (TTM):
$1.18
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $102.3M $119.1M $140.8M $214.2M $398.2M
Revenue Growth (YoY) 20361.2% 16.39% 18.28% 52.1% 85.9%
 
Cost of Revenues $14.8M $17M $21.9M $34.4M $52M
Gross Profit $87.5M $102M $118.9M $179.8M $346.2M
Gross Profit Margin 85.57% 85.69% 84.46% 83.94% 86.95%
 
R&D Expenses $18.8M $16.5M $16.9M $19.8M $93.2M
Selling, General & Admin $36.9M $44.2M $49.6M $57.1M $133.7M
Other Inc / (Exp) $1.6M $587K $282K $2.9M $7.7M
Operating Expenses $55.7M $60.7M $66.6M $78M $259.4M
Operating Income $31.8M $41.3M $52.4M $101.8M $86.8M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $33.4M $41.9M $52.7M $104.7M $94.5M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $1.5M -$33.1M $13.2M $21.6M $23.1M
Net Income to Company $31.9M $75M $39.5M $83.1M $71.4M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $31.9M $75M $39.5M $83.1M $71.4M
 
Basic EPS (Cont. Ops) $0.31 $0.72 $0.38 $0.80 $0.67
Diluted EPS (Cont. Ops) $0.30 $0.71 $0.37 $0.75 $0.63
Weighted Average Basic Share $102.9M $103.5M $103.4M $103.4M $106.3M
Weighted Average Diluted Share $106M $106.2M $107.8M $111.4M $113.8M
 
EBITDA $31.9M $41.4M $52.6M $103.1M $119.7M
EBIT $31.8M $41.3M $52.4M $101.8M $86.8M
 
Revenue (Reported) $102.3M $119.1M $140.8M $214.2M $398.2M
Operating Income (Reported) $31.8M $41.3M $52.4M $101.8M $86.8M
Operating Income (Adjusted) $31.8M $41.3M $52.4M $101.8M $86.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $29.3M $36M $57.2M $102.7M $128.7M
Revenue Growth (YoY) -5.12% 22.64% 59.22% 79.39% 25.33%
 
Cost of Revenues $3.9M $5.3M $9.7M $14.2M $19.3M
Gross Profit $25.4M $30.6M $47.6M $88.5M $109.4M
Gross Profit Margin 86.77% 85.23% 83.12% 86.2% 85.02%
 
R&D Expenses $3.7M $4.5M $8.3M $83.7M $3.3M
Selling, General & Admin $10M $12.2M $13.6M $33.6M $45.9M
Other Inc / (Exp) $33K $68K $905K -$568K $1.8M
Operating Expenses $13.7M $16.6M $22.5M $125.7M $58.5M
Operating Income $11.7M $14M $25.1M -$37.2M $50.9M
 
Net Interest Expenses -- -- -- $265K --
EBT. Incl. Unusual Items $11.7M $14.1M $26M -$38M $57.2M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$31.6M $3.7M $3.3M -$7.3M $13.3M
Net Income to Company $43.3M $10.3M $22.7M -$30.8M $43.9M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $43.3M $10.3M $22.7M -$30.8M $43.9M
 
Basic EPS (Cont. Ops) $0.42 $0.10 $0.22 -$0.29 $0.37
Diluted EPS (Cont. Ops) $0.41 $0.10 $0.20 -$0.29 $0.35
Weighted Average Basic Share $103.5M $103.2M $103.3M $106.6M $118.9M
Weighted Average Diluted Share $106.3M $107.8M $112M $106.6M $125.4M
 
EBITDA $11.7M $14M $25.7M -$28.6M $60.4M
EBIT $11.7M $14M $25.1M -$37.2M $50.9M
 
Revenue (Reported) $29.3M $36M $57.2M $102.7M $128.7M
Operating Income (Reported) $11.7M $14M $25.1M -$37.2M $50.9M
Operating Income (Adjusted) $11.7M $14M $25.1M -$37.2M $50.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $118.2M $133.5M $191.8M $348.4M $460.5M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $16.6M $19.4M $30.5M $47.4M $63M
Gross Profit $101.6M $114.1M $161.2M $301M $397.5M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $18.6M $16.1M $20.7M $95.3M $10.8M
Selling, General & Admin $42.3M $49.8M $56.2M $105.8M $175.6M
Other Inc / (Exp) $878.9K $317K $745K $3.3M $9.7M
Operating Expenses $60.9M $65.9M $77.4M $225.1M $223.5M
Operating Income $40.7M $48.3M $83.8M $75.9M $174M
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items $41.6M $48.6M $84.5M $80.8M $188.8M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$29.9M $7M $17.6M $18.8M $46M
Net Income to Company $71.5M $41.6M $66.9M $62M $142.8M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $71.5M $41.6M $66.9M $62M $142.8M
 
Basic EPS (Cont. Ops) $0.69 $0.40 $0.65 $0.59 $1.25
Diluted EPS (Cont. Ops) $0.67 $0.39 $0.61 $0.52 $1.18
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $40.8M $48.4M $84.4M $100.3M $211.4M
EBIT $40.7M $48.3M $83.8M $75.9M $174M
 
Revenue (Reported) $118.2M $133.5M $191.8M $348.4M $460.5M
Operating Income (Reported) $40.7M $48.3M $83.8M $75.9M $174M
Operating Income (Adjusted) $40.7M $48.3M $83.8M $75.9M $174M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $88.1M $102.5M $153.4M $287.6M $349.9M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $12.2M $14.5M $23.2M $36.2M $47.2M
Gross Profit $75.9M $88M $130.2M $251.5M $302.7M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $12.3M $11.9M $15.7M $91.2M $8.9M
Selling, General & Admin $30.9M $36.4M $43M $91.7M $133.5M
Other Inc / (Exp) $480K $211K $674K $1.1M $1.5M
Operating Expenses $43.2M $48.3M $59.2M $206.4M $170.4M
Operating Income $32.7M $39.6M $71M $45.1M $132.3M
 
Net Interest Expenses -- -- -- $265K --
EBT. Incl. Unusual Items $33.2M $39.9M $71.7M $47.8M $142.1M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$30.4M $9.7M $14.1M $11.2M $34.1M
Net Income to Company $63.5M $30.2M $57.6M $36.6M $108M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items $63.5M $30.2M $57.6M $36.6M $108M
 
Basic EPS (Cont. Ops) $0.61 $0.29 $0.56 $0.35 $0.92
Diluted EPS (Cont. Ops) $0.60 $0.28 $0.52 $0.30 $0.87
Weighted Average Basic Share $310.4M $310.4M $308.9M $318.4M $353.9M
Weighted Average Diluted Share $319.6M $322.3M $330.3M $334.2M $373.5M
 
EBITDA $32.8M $39.8M $71.7M $68.9M $160.6M
EBIT $32.7M $39.6M $71M $45.1M $132.3M
 
Revenue (Reported) $88.1M $102.5M $153.4M $287.6M $349.9M
Operating Income (Reported) $32.7M $39.6M $71M $45.1M $132.3M
Operating Income (Adjusted) $32.7M $39.6M $71M $45.1M $132.3M
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $89.5M $130.2M $171.4M $298.4M $137.6M
Short Term Investments $5M $10M $19.8M -- --
Accounts Receivable, Net $10.5M $6M $6.6M $10.4M $53.5M
Inventory $2M $4.7M $7.9M $6.8M $15.6M
Prepaid Expenses $3.8M $7.4M $3.9M $4.8M $12.4M
Other Current Assets $516.7K $883K $432K $354K $138K
Total Current Assets $111.4M $159.2M $210.1M $320.8M $219.3M
 
Property Plant And Equipment $1M $130K $4M $3.6M $3.7M
Long-Term Investments -- -- -- -- $16.5M
Goodwill -- -- -- -- --
Other Intangibles -- -- -- $32.5M $194M
Other Long-Term Assets -- -- -- -- --
Total Assets $112.4M $192.4M $237.8M $375.6M $470.1M
 
Accounts Payable $4.1M $4.3M $2.8M $4M $14.8M
Accrued Expenses $14.9M $14.4M $19.6M $26.1M $38.3M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $300.5K $29K $308K $337K $369K
Other Current Liabilities $172.3K $106K $243K $238K $465K
Total Current Liabilities $24.1M $22.8M $27.1M $57.6M $76.1M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $24.7M $22.8M $31M $75.2M $82.2M
 
Common Stock $103.4K $104K $103K $105K $107K
Other Common Equity Adj $9.5K $31K -$148K $24K $14K
Common Equity $87.6M $169.6M $206.8M $300.4M $387.9M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $87.6M $169.6M $206.8M $300.4M $387.9M
 
Total Liabilities and Equity $112.4M $192.4M $237.8M $375.6M $470.1M
Cash and Short Terms $94.5M $140.3M $191.3M $298.4M $137.6M
Total Debt -- -- -- -- --
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $117.1M $154.8M $256.1M $121M $442.3M
Short Term Investments $10M $20M -- -- --
Accounts Receivable, Net $5.9M $6.6M $9.3M $48M $58.3M
Inventory $4.7M $7M $7.1M $9M $20M
Prepaid Expenses $4.7M $4M $3M $13.6M $17.9M
Other Current Assets $896.3K $425K $790K $352K $509K
Total Current Assets $143.3M $192.8M $276.3M $192M $539M
 
Property Plant And Equipment $161.3K $4M $3.7M $3.8M $3.7M
Long-Term Investments -- -- -- $12.9M $14.8M
Goodwill -- -- -- -- --
Other Intangibles -- -- $33.1M $167.1M $166M
Other Long-Term Assets -- -- -- -- --
Total Assets $174.9M $223.2M $333.1M $413.2M $772M
 
Accounts Payable $2M $2.8M $2.5M $4.6M $11.6M
Accrued Expenses $12.6M $14.5M $21.5M $34.2M $82.1M
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $114.6K $278K $330K $361K $393K
Other Current Liabilities $69.6K $110K $237K $374K $449K
Total Current Liabilities $18.2M $20.6M $44.7M $57.8M $105.4M
 
Long-Term Debt -- -- -- -- --
Capital Leases -- -- -- -- --
Total Liabilities $18.2M $24.6M $63.1M $64.7M $111.1M
 
Common Stock $103.7K $103K $104K $107K $119K
Other Common Equity Adj -$6.5K -$63K $32K $15K --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $156.6M $198.7M $270M $348.5M $660.9M
 
Total Liabilities and Equity $174.9M $223.2M $333.1M $413.2M $772M
Cash and Short Terms $127.1M $174.8M $256.1M $121M $442.3M
Total Debt -- -- -- -- --
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $31.9M $75M $39.5M $83.1M $71.4M
Depreciation & Amoritzation $55K $92K $192K $1.2M $32.9M
Stock-Based Compensation $3.8M $6.3M $6.1M $7.9M $14.3M
Change in Accounts Receivable -$10.5M $4.5M -$632K -$3.8M -$43.1M
Change in Inventories -$1.9M -$2.7M -$3.2M $1.1M -$4.7M
Cash From Operations $34.6M $45M $60.4M $116M $143.6M
 
Capital Expenditures $19K $11K $1M $29K $81.7M
Cash Acquisitions -- -- -- -- --
Cash From Investing $37.2M -$5M -$11M $9.2M -$293.5M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -$12.1M -$6.9M --
Other Financing Activities -- -$56K -$153K -$968K -$13.6M
Cash From Financing $1.1M $702K -$8.1M $1.7M -$10.9M
 
Beginning Cash (CF) $16.6M $89.5M $130.2M $171.4M $298.4M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $73M $40.7M $41.2M $127M -$160.8M
Ending Cash (CF) $89.5M $130.2M $171.4M $298.4M $137.6M
 
Levered Free Cash Flow $34.6M $45M $59.4M $116M $61.9M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $43.3M $10.3M $22.7M -$30.8M $43.9M
Depreciation & Amoritzation $30K $31K $553K $8.6M $9.5M
Stock-Based Compensation $1.5M $1.5M $2.1M $3.8M $4.4M
Change in Accounts Receivable $890K -$333K $250K -$5.3M -$1.1M
Change in Inventories -$2.9M $147K $718K $1.7M -$2M
Cash From Operations $11.5M $21.7M $41.3M $45.1M $72.9M
 
Capital Expenditures $11K $68K -- $79.4M $259K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$10M -$68K -$132K -$92.8M -$259K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -$5.1M -- -- --
Other Financing Activities -$17K -- -- -$10.3M -$10M
Cash From Financing $614K -$2.1M $4M -$10.1M -$6M
 
Beginning Cash (CF) $115.1M $135.3M $210.9M $178.8M $375.7M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $2.1M $19.5M $45.2M -$57.8M $66.6M
Ending Cash (CF) $117.1M $154.8M $256.1M $121M $442.3M
 
Levered Free Cash Flow $11.4M $21.6M $41.3M -$34.2M $72.6M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $71.5M $41.6M $66.9M $62M $142.8M
Depreciation & Amoritzation -$80K $178K $657K $24.4M $37.5M
Stock-Based Compensation $5.9M $6.1M $7.5M $11.9M $21.3M
Change in Accounts Receivable $4.2M -$754K -$2.7M -$38.7M -$10.2M
Change in Inventories -$4.1M -$2.2M -$182K $2.2M -$11M
Cash From Operations $44.2M $54.3M $95.1M $128M $224.6M
 
Capital Expenditures $10.6K $980K $70K $79.4M $2.8M
Cash Acquisitions -- -- -- -- --
Cash From Investing $26.6M -$11M $9.2M -$255.2M -$38.8M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -$9M -$10M -- -$296K
Other Financing Activities -- -- -- -$13.2M -$13.4M
Cash From Financing $1.3M -$5.6M -$3.1M -$7.9M $135.6M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $72.1M $37.7M $101.2M -$135.1M $321.4M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $44.2M $53.3M $95.1M $48.6M $221.8M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $63.5M $30.2M $57.6M $36.6M $108M
Depreciation & Amoritzation $73K $159K $624K $23.7M $28.3M
Stock-Based Compensation $4.8M $4.6M $6M $10M $17.1M
Change in Accounts Receivable $4.7M -$638K -$2.7M -$37.6M -$4.8M
Change in Inventories -$2.8M -$2.3M $738K $1.9M -$4.4M
Cash From Operations $31.9M $41.2M $76M $88M $168.9M
 
Capital Expenditures $11K $980K $29K $79.4M $468K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$5M -$11M $9.2M -$255.2M -$468K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -$9M -$6.9M -- -$296K
Other Financing Activities -$17K -$17K -$20K -$12.3M -$12M
Cash From Financing $676K -$5.6M -$559K -$10.2M $136.2M
 
Beginning Cash (CF) $306.3M $392.9M $560.7M $625.4M $823.7M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $27.6M $24.6M $84.6M -$177.4M $304.7M
Ending Cash (CF) $333.9M $417.5M $645.3M $448M $1.1B
 
Levered Free Cash Flow $31.9M $40.2M $75.9M $8.5M $168.5M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock